Biopolymer Membranes and Films 2020
DOI: 10.1016/b978-0-12-818134-8.00006-7
|View full text |Cite
|
Sign up to set email alerts
|

Biopolymer membranes in tissue engineering

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 81 publications
0
3
0
Order By: Relevance
“…CHT has a structure composed of repeating units of N-acetyl-2-amino-2-deoxy-d-glucopyranose (acetylated unit) and 2-amino-2-deoxy-glucopyranose (deacetylated unit), which are linked by β-(1→4)-glycosidic bonds [3]. It displays interesting physical, structural, and chemical features, which result in film-forming ability, antibacterial action, biocompatibility, and biodegradability [3,7,8]. Moreover, CHT's cationic nature encourages the interaction of the available functional groups in its structure with different molecules, polysaccharides, and proteins, opening possibilities for designing transdermal drug-release systems, wound dressings, in vitro models, and other tissue-engineering applications [3,[9][10][11][12].…”
Section: Introductionmentioning
confidence: 99%
“…CHT has a structure composed of repeating units of N-acetyl-2-amino-2-deoxy-d-glucopyranose (acetylated unit) and 2-amino-2-deoxy-glucopyranose (deacetylated unit), which are linked by β-(1→4)-glycosidic bonds [3]. It displays interesting physical, structural, and chemical features, which result in film-forming ability, antibacterial action, biocompatibility, and biodegradability [3,7,8]. Moreover, CHT's cationic nature encourages the interaction of the available functional groups in its structure with different molecules, polysaccharides, and proteins, opening possibilities for designing transdermal drug-release systems, wound dressings, in vitro models, and other tissue-engineering applications [3,[9][10][11][12].…”
Section: Introductionmentioning
confidence: 99%
“…For all of these qualities, they are used, for example, as materials for transporting pharmaceutical molecules and substances (such as enzymes, antibiotics and antineoplastic drugs, etc. ), in ocular, dental, nasal and other systems [153,229,230]. Biopolymers from different sources and that have pharmaceutically active ingredients (capable of influencing the drug delivery process), are used for the production of Drug Delivery Systems (DDS), usually in the form of microcapsules, microspheres, nanospheres, hydrogels, nanogels and liposomes [153,229].…”
Section: Biopolymers In Pharmacology and Medicinementioning
confidence: 99%
“…Ideally, these scaffolds should accomplish some basic principles for tissue engineering by: (i) showing specific biological properties such as nontoxicity, biocompatibility, low antigenicity and biodegradability, (ii) integrating well with the surrounding tissues; (iii) coping with the biomechanical stress, such as in locomotion; (iv) supporting the total integrity of cells and their viability that include proliferation and differentiation; and (v) promoting the natural ingrowth of the native tissue; among others [ 3 , 12 ]. In fact, biocompatibility is a critical concern and new scaffolds should cause only a negligible immune response and avoid severe inflammation, which is associated with a decreased healing rate and, in some cases, rejection by the human body [ 13 ].…”
Section: Introductionmentioning
confidence: 99%